Clinical trial
Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With…
NCT00450567 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00450567 |
|---|---|
| Title | Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy |
| Official title | Monitoring Targeted Lung Cancer Treatments With FDG-PET/CT |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Lung Cancer |
| Intervention type | Procedure, Radiation |
| Interventions | computed tomography, positron emission tomography, fludeoxyglucose F 18 |
| Enrollment | 36 |
| Start date | Dec 1, 2004 |
| Primary completion | Jul 1, 2012 |
| Completion | Jul 1, 2012 |
| First posted | Mar 22, 2007 |
| Last update posted | Aug 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: